FDA reverses NMN decision

Agency responds to petition by Natural Products Association and Alliance for Natural Health, allowing NMN as a dietary supplement. Once feted as a promising addition to the NAD+ supplement landscape, nicotinamide mononucleotide (NMN) found itself at the center of regulatory turbulence when the US Food and Drug Administration (FDA) concluded in 2022 that the compound […] The post FDA reverses NMN decision appeared first on Longevity.Technology.